Gundo Diedrich is Executive Director of Antibody Engineering at MacroGenics. His work focuses on the discovery, engineering, and expression of antibodies as well as the development of the company’s multispecific antibody platform. Gundo received a Ph.D. in Chemistry from the Max-Planck Institute for Molecular Genetics in Berlin, completed postdoctoral training in immunology at Yale University, and worked as a Research Scientist in antibody discovery at Targeted Molecules, diaDexus, and Medimmune before joining MacroGenics in 2015.